NASDAQ: DSGN
Design Therapeutics Inc Stock Ownership - Who owns Design Therapeutics?

Insider buying vs selling

Have Design Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arsani WilliamDirector2025-08-13345,000$5.25
$1.81MSell
Arsani WilliamDirector2025-08-13217,627$5.25
$1.14MSell

1 of 1

DSGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DSGN insiders and whales buy or sell their stock.

DSGN Shareholders

What type of owners hold Design Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Simeon George21.33%12,152,952$123.11MInsider
Sr One Capital Fund I Aggregator LP11.46%6,526,476$66.11MInsider
Sr One Capital Management LP11.46%6,526,476$66.11MInstitution
Arsani William9.98%5,687,501$57.61MInsider
Cormorant Asset Management LP8.98%5,114,844$51.81MInsider
Quan Venture Fund II LP8.29%4,720,830$47.82MInsider
Stella Xu7.27%4,139,950$41.94MInsider
Logos Global Management LP6.42%3,655,000$37.03MInstitution
Point72 Asset Management LP5.86%3,340,552$33.84MInstitution
Blackrock Inc3.59%2,044,388$20.71MInstitution

1 of 3

DSGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DSGN45.88%54.12%Net Selling
REPL66.37%33.63%Net SellingNet Selling
DNA9.27%90.73%Net SellingNet Selling
LENZ49.80%50.20%Net SellingNet Buying
FULC65.04%34.96%Net SellingNet Selling

Design Therapeutics Stock Ownership FAQ

Who owns Design Therapeutics?

Design Therapeutics (NASDAQ: DSGN) is owned by 60.55% institutional shareholders, 71.44% Design Therapeutics insiders, and 0.00% retail investors. Simeon George is the largest individual Design Therapeutics shareholder, owning 12.15M shares representing 21.33% of the company. Simeon George's Design Therapeutics shares are currently valued at $123.11M.

If you're new to stock investing, here's how to buy Design Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.